Corrigendum to "Review of the renal endpoints used in cardiovascular safety clinical trials in type 2 diabetes mellitus patients and their importance in primary care" [Primary Care Diabetes 13 (6) (2019) 485-494]

. (2020). Corrigendum to "Review of the renal endpoints used in cardiovascular safety clinical trials in type 2 diabetes mellitus patients and their importance in primary care" [Primary Care Diabetes 13 (6) (2019) 485-494]. PRIMARY CARE DIABETES, 14(-), 186-187. SID. https://sid.ir/paper/761808/en

. Corrigendum to "Review of the renal endpoints used in cardiovascular safety clinical trials in type 2 diabetes mellitus patients and their importance in primary care" [Primary Care Diabetes 13 (6) (2019) 485-494]. PRIMARY CARE DIABETES[Internet]. 2020;14(-):186-187. Available from: https://sid.ir/paper/761808/en

, “Corrigendum to "Review of the renal endpoints used in cardiovascular safety clinical trials in type 2 diabetes mellitus patients and their importance in primary care" [Primary Care Diabetes 13 (6) (2019) 485-494],” PRIMARY CARE DIABETES, vol. 14, no. -, pp. 186–187, 2020, [Online]. Available: https://sid.ir/paper/761808/en